Global Genome (DNA) Sequencing Market Growth (Status and Outlook) 2023-2029

Global Genome (DNA) Sequencing Market Growth (Status and Outlook) 2023-2029

The global Genome (DNA) Sequencing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Genome (DNA) Sequencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Genome (DNA) Sequencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Genome (DNA) Sequencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Genome (DNA) Sequencing players cover Agilent Technologies Inc., BGI, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche Ltd., Genome Electric Company, Illumina Inc., IntegraGen and Oxford Nanopore Technologies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Genome (DNA) sequencing is a method that allows several DNA strands to be sequenced simultaneously. Genome sequencing technology aids in the sequencing of an organism's whole genome in order to determine the order or sequence of DNA nucleotides or bases coded with letters including As, Gs, Cs, and Ts. Genome sequencing methods made it feasible to investigate genetics, biomarkers, forensics, customized medicine, and other fields. This technology aids in the transition from traditional procedures to customized medications with the use of genetics. It is a widely utilized method for whole-genome sequencing.

LPI (LP Information)' newest research report, the “Genome (DNA) Sequencing Industry Forecast” looks at past sales and reviews total world Genome (DNA) Sequencing sales in 2022, providing a comprehensive analysis by region and market sector of projected Genome (DNA) Sequencing sales for 2023 through 2029. With Genome (DNA) Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genome (DNA) Sequencing industry.

This Insight Report provides a comprehensive analysis of the global Genome (DNA) Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Genome (DNA) Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Genome (DNA) Sequencing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genome (DNA) Sequencing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genome (DNA) Sequencing.

This report presents a comprehensive overview, market shares, and growth opportunities of Genome (DNA) Sequencing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Next-Generation Sequencing
Third Generation DNA Sequencing
Others

Segmentation by application
Research Institutes
Pharmaceutical & Biotechnological Companies
Healthcare Facilities & Diagnostic Centres

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Agilent Technologies Inc.
BGI
Bio-Rad Laboratories
Danaher
F. Hoffmann-La Roche Ltd.
Genome Electric Company
Illumina Inc.
IntegraGen
Oxford Nanopore Technologies
Pacific Biosciences of California Inc.
QIAGEN
Thermo Fisher Scientific Inc.

Please note: The report will take approximately 2 business days to prepare and deliver.